← Open Payments lookup

HEATHER LEMASTER: Open Payments

NPI 1508567363 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,909 in 106 payments from 24 companies in 2025. Trend: 2023 $669 · 2024 $1,044 · 2025 $1,909

Food & beverage: $1,902Education: $8
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.14$412
ABBVIE INC.18$256
Supernus Pharmaceuticals, Inc.18$190
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$164
AstraZeneca Pharmaceuticals LP5$107
Teva Pharmaceuticals USA, Inc.5$99
Bayer Healthcare Pharmaceuticals Inc.5$81
Axsome Therapeutics, Inc.3$79
Lilly USA, LLC4$66
Janssen Pharmaceuticals, Inc2$61

Products named: VRAYLAR, HETLIOZ, Qelbree, FANAPT, CAPLYTA, FARXIGA, Kerendia, Auvelity.

Industry payments across KY — which companies pay providers there.